Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | AZD0754 |
Synonyms | |
Therapy Description |
AZD0754 are T-cells engineered to express a dominant negative TGF-beta type II receptor and a chimeric antigen receptor (CAR) targeting STEAP2, which potentially decrease growth of STEAP2-expressing tumors (PMID: 37966111). |